Insulin Glulisine and Octreotide Interaction

Drug interaction information between Insulin Glulisine and Octreotide.

Insulin Glulisine and Octreotide have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Insulin Glulisine and Octreotide. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Insulin Glulisine

Rapid-Acting Insulin

Drug B

Octreotide

Somatostatin Analog

How They Interact

Octreotide can increase the risk of low blood sugar when taken with insulin.

FDA Label Information

7 DRUG INTERACTIONS Table 6: Clinically Significant Drug Interactions with APIDRA Drugs that May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics.

Insulin Glulisine Also Interacts With

View all Insulin Glulisine interactions →

Frequently Asked Questions

What SPL severity band is on file for Insulin Glulisine + Octreotide?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Octreotide has 14 labeled pairs on file vs Insulin Glulisine's 9. In the moderate band specifically: Insulin Glulisine has 3 (also Fluoxetine, Pramlintide); Octreotide has 9 (also Insulin Aspart, Insulin Degludec, Insulin Detemir, Insulin Glargine).

What mechanism field is on file for Insulin Glulisine and Octreotide?

Octreotide can increase the risk of low blood sugar when taken with insulin.

Octreotide's labeled portfolio outnumbers Insulin Glulisine

SPL source-record counts only. This page's band is moderate · classes on file: Insulin Glulisine (Rapid-Acting Insulin); Octreotide (Somatostatin Analog).

Insulin Glulisine

0 major · 3 moderate · 6 minor · 9 total

Octreotide

0 major · 9 moderate · 5 minor · 14 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.